AUDUBON, Pa. , Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt ....
AUDUBON, Pa. , Sept. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized Orthopedics’ (NSO) Precice Bone Transport system in targeted regions....
—Creates leading global musculoskeletal company— —Robust portfolio well-positioned for long-term growth and continued innovation— AUDUBON, Pa. , Sept. 01, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its...
AUDUBON, Pa. , Aug. 03, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2023 . Worldwide net sales were $291.6 million , an increase of 10.6% GAAP net income for the quarter...
MARVEL™ is Globus Medical’s second major release this year in the pediatric scoliosis space AUDUBON, Pa. , July 31, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the MARVEL™ Growing Rod System, which...
AUDUBON, Pa. , July 13, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 3, 2023 ....
REFLECT™ is approved through the FDA’s Humanitarian Device Exemption pathway AUDUBON, Pa. , May 15, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the REFLECT ™ Scoliosis Correction System has been granted approval from the...
AUDUBON, Pa. , May 04, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2023 . Worldwide net sales were $276.7 million , an increase of 20.0%, or 21.0% on a constant...
AUDUBON, Pa. , April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common...
AUDUBON, Pa. , April 19, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, 2023 ....
